MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

Phase 1

Completed

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: Panitumumab
Drug: Carboplatin
Drug: Paclitaxel
Radiation: Intensity Modulated Radiation Therapy
Drug: 5-Fluorouracil
Drug: Docetaxel
Drug: Cisplatin

First Posted Date: 2007-08-08

Last Posted Date: 2017-03-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 34

Registration Number: NCT00513383

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia

Phase 1

Completed

Conditions: Leukemia

First Posted Date: 2007-07-23

Last Posted Date: 2010-09-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 36

Registration Number: NCT00505700

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel/ Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home

Not Applicable

Completed

Conditions: Major Depressive Disorder

First Posted Date: 2007-07-23

Last Posted Date: 2013-09-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 9

Registration Number: NCT00505518

Locations: 🇺🇸
South Cove Manor, Boston, Massachusetts, United States
🇺🇸
Depression and Clinical Research Program at Massachusetts General Hospital, Boston, Massachusetts, United States

Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics

Terminated

Conditions: Chronic Pain

Interventions: Drug: Tramadol Extended Release Oral Capsule
Drug: Benadryl

First Posted Date: 2007-07-23

Last Posted Date: 2020-07-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 7

Registration Number: NCT00505531

Locations: 🇺🇸
MGH Center for Translational Pain Research, Boston, Massachusetts, United States

Accelerated Mortality on Renal Replacement

Completed

Conditions: End Stage Renal Disease

First Posted Date: 2007-07-23

Last Posted Date: 2007-07-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 10018

Registration Number: NCT00505180

Two Approaches to Routine HIV Testing in a Hospital Emergency Department

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: Counselor-based HIV screening
Behavioral: Emergency staff member-based HIV screening

First Posted Date: 2007-07-18

Last Posted Date: 2012-07-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4855

Registration Number: NCT00502944

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism

Phase 3

Completed

Conditions: Autism

Interventions: Drug: Placebo
Drug: Atomoxetine

First Posted Date: 2007-07-09

Last Posted Date: 2017-08-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT00498173

Locations: 🇺🇸
Lurie Center - MassGeneral Hospital, Lexington, Massachusetts, United States
🇺🇸
Christian Sarkine Autism Treatment Center at Riley Hospital for Children, Indianapolis, Indiana, United States

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

Phase 1

Completed

Conditions: Kallmann Syndrome
Idiopathic Hypogonadotropic Hypogonadism
GnRH Deficiency

First Posted Date: 2007-06-29

Last Posted Date: 2022-07-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 27

Registration Number: NCT00493961

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders

Completed

Conditions: Puberty, Delayed
Puberty, Precocious
Hypogonadotropic Hypogonadism
Kallmann Syndrome
GnRH Deficiency

First Posted Date: 2007-06-29

Last Posted Date: 2022-06-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4042

Registration Number: NCT00494169

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Vitamin D Deficiency, Insulin Resistance and FGF-23

Not Applicable

Completed

Conditions: Vitamin D Deficiency

Interventions: Dietary Supplement: Ergocalciferol placebo
Dietary Supplement: Ergocalciferol

First Posted Date: 2007-06-26

Last Posted Date: 2018-05-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 92

Registration Number: NCT00491322

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy